The federal Food and Drug Administration has announced that a batch of birth control pills has been recalled because of a packaging error that may leave women at risk of unintended pregnancy.
On Feb. 24, Glenmark Generics Inc. USA – the domestic distributor for Glenmark Generics Ltd. India – issued the recall of seven lots of norgestimate and ethinyl estradiol tablets.
According to a release by Glenmark, select blisters on the packaging were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch. As a result, the daily regimen may be incorrect and could leave women without adequate contraception.
The FDA recommends that consumers exposed to the affected packaging should start using a non-hormonal form of contraception immediately. Patients who have the affected product should notify their physician and return the product to the pharmacy.
For a listing of affected lot numbers and expiration dates, go here:
https://www.fda.gov/Safety/Recalls/ucm293347.htm
